Non-hormonal treatment of hot flushes in breast cancer survivors: Gabapentin vs. vitamin e

Climacteric

Volumn 12, Issue 4, 2009, Pages 310-318

  Biglia, N ^a   Sgandurra, P ^a   Peano, E ^a   Marenco, D ^a   Moggio, G ^a   Bounous, V ^a   Tomasi Cont, N ^a   Ponzone, R ^a   Sismondi, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast cancer survivors; Gabapentin; Hot flushes; Menopausal symptoms; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GABAPENTIN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CONTROLLED STUDY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EARLY MENOPAUSE; FEMALE; HEALTH SURVEY; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SLEEP PATTERN; SOMNOLENCE; VASOMOTOR DISORDER;

ADULT; AGED; AMINES; BREAST NEOPLASMS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP; SURVIVORS; TAMOXIFEN; VITAMIN E;

EID: 70350596476     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902736921     Document Type: Article

References (16)

1. Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006;9:49-58
2. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11:11-13
3. Holmberg L, Iversen OE, Rudenstam CM, et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 2008;100:475-482
4. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flushes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-2063
5. Biglia N, Kubatzki F, Sgandurra P, et al. Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial. Breast J 2007;13:490-495
6. Guttuso TJ Jr. Gapabentin's effects on hot flashes and hypothermia. Neurology 2000; 54:2161-2163
7. Guttuso TJ Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101: 337-345
8. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008;15:310-318
9. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005;366: 818-824
10. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495-500
11. Sloan JA, Loprinzi CL, Novonty PJ, et al. Methodologic lesson learned from hot flushes studies. J Clin Oncol 2001;19:4280-4290
12. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213
13. Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS): a methodological review. Health Qual Life Outcomes 2004; 2-45
14. Ware J Jr, Snow K, Konsinski M, et al. SF-36 Health Survey. Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993
15. Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 2003;45:29-38
16. Heinemann LAJ, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HPG. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2004;2-67